Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype

Diabetes

Volumn 48, Issue 10, 1999, Pages 1979-1986

  Flamez, Daisy ^a   Gilon, Patrick ^b   Moens, Karen ^a   Van Breusegem, An ^a   Delmeire, Dominique ^a   Scrocchi, Louise A ^c   Henquin, Jean Claude ^b   Drucker, Daniel J ^c   Schuit, Frans ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; INSULIN; ACETYLCHOLINE; DIAZOXIDE; EXENDIN (9 39) AMIDE; EXENDIN (9-39) AMIDE; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; GLUCOSE; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; FEMALE; GLUCOSE TRANSPORT; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; MOUSE MUTANT; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; CALCIUM; CELLS, CULTURED; CYCLIC AMP; DIAZOXIDE; FEMALE; GLUCOSE; ISLETS OF LANGERHANS; MALE; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PHENOTYPE; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 0032589352     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.10.1979     Document Type: Article

References (44)

1. Elrick H, Stimmler L, Hlad CJ Jr, Arai Y: Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 24:1076-1082, 1964
2. Creutzfeldt W: The incretin concept today Diabetologia 16:75-85, 1979
3. Nauck M, Stockmann F, Ebert R, Creutzfeldt W: Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46-52, 1986
4. Drucker DJ. Glucagon-like peptides. Diabetes 47:159-169, 1998
5. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307, 1993
6. Ebert R, Illmer K, Creutzfeldt W: Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Gastroenterology 76:515-523, 1979
7. Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B: Exendin-4 is a high potency agonist and truncated exendin (9-39)amide an antagonist at the glucagon-like peptide 1 (7-36)amide receptor of insulin-secreting β-cells. J Biol Chem 268:19650-19655, 1993
8. Scrocchi LA, Brown TJ, Maclusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
9. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S: Antidiabetogenic effects of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. New Engl J Med 326:1316-1322, 1992
10. Holz GG IV, Kühtreiber WM, Habener JF: Pancreatic bela-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-37). Nature 361:362-365, 1993
11. Montrose-Rafizadeh C, Wang Y. Janczewski AM, Henderson TE, Egan JM: Over-expression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness. Mol Cell Endocrinol 130:109-117, 1997
12. Flamez D, Van Breusegem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F: Mouse pancreatic β-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes 47:646-652, 1998
13. Pederson RA, Satkunarajah M, McIntosh CHS, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB: Enhanced GIP secretion and insulinotropic action in glucagon-like peptide receptor -/- mice. Diabetes 47:1046-1052, 1998
14. Moens K, Flamez D, Van Schravendijk C, Ling Z, Pipeleers D, Schuit F: Dual glucagon recognition by pancreatic β-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes 47:66-72, 1998
15. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F: Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261, 1996
16. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF: Glucagon-like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 84:3434-3438, 1987
17. Fehmann HC, Janssen M, Goke B: Interaction of glucagon-like peptide-1 (GLP-1) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells. Acta Diabetologia 32:176-181, 1995
18. Gromada J, Holst JJ, Rorsman P: Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide-1. Pflügers Arch Eur J Physiol 435:583-594, 1998
19. Pipeleers DG, Schuit FC, In't Veld P, Maes E, Hooghe-Peters EL, Van De Winkel M, Gepts W: Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology 117:824-833, 1985
20. Schuit FC, Pipeleers DG: Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117:834-840, 1985
21. Ämmälä C, Ashcroft FM, Rorsman P: Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 363:356-358, 1993
22. Henquin JC, Meissner HP: The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cell: studies with forskolin. Endocrinology 115:1125-1134, 1984
23. 2+ as evidenced in single pancreatic islets. J Biol Chem 268:22265-22268, 1993
24. 2+ and secretion. EMBO J 9:53-60, 1990
25. Ling Z, Kiekens R, Mahler T, Schuit FC, Pipeleers-Marichal M, Sener A, Kloppel G, Malaisse WJ, Pipeleers DG: Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes 45:1774-82, 1996
26. 2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J Biol Chem 267:20713-20720, 1992
27. Renström E, Eliasson L, Rorsman P: Protein kinase-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 502:105-118, 1997
28. 2+ in the electrically excitable pancreatic β-cell. Biochem J 311:259-267, 1995
29. Thorens B: Expression cloning of the pancreatic β-cell receptor for the glucoincretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 89: 8641-8645, 1992
30. Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM: Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). J Clin Invest 98:2440-2445, 1996
31. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR: Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest 95:417-421, 1995
32. Schuit FC, In't Veld PA, Pipeleers DG: Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci U S A 85:3865-3869, 1988
33. Kiekens R, In't Veld P, Mahler T, Schuit F, Van De Winkel M, Pipeleers D: Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest 89:117-125, 1992
34. Heimberg H, De Vos A, Vandercammen A, Van Schaftingen E, Pipeleers D, Schuit F: Heterogeneity in glucose sensitivity among pancreatic β-cells is correlated to differences in glucose phosphorylation rather than in glucose transport. EMBO J 12:2873-2879, 1993
35. Serre V, Dolci W, Schaerer E, Scrocchi L, Drucker D, Efrat S, Thorens B: Exendin (9-39)amide is an inverse agonist of the murine GLP-1 receptor implications for basal intracellular cyclic adenosire 3′, 5′-monophosphate levels and β-cell glucose competence. Endocrinology 139:4448-4454, 1998
36. Lester LB, Langeberg LK, Scott JD: Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci U S A 94: 14942-14947, 1997
37. Sammak PJ, Adams SR, Harootunian AR, Schliwa M, Tsien RY: Intracellular cAMP not calcium, determines the direction of vesicle movement in melanophores: direct measurement by fluorescence ratio imaging. J Cell Biol 117:57-72, 1992
38. 2+-signaling pathway in pancreatic β-cells by the insulinotropic hormone GLP-1. J Biol Chem 270:17749-17757, 1995
39. Gromada J, Rorsman P: Molecular mechanism underlying GLP-1 induced calcium mobilization from internal stores in insulin-secreting β-TC3 cells. Acta Physiol Scand 157:349-351, 1996
40. + channels in mouse β-cells. J Clin Invest 89:1288-1295, 1992
41. Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN, Mintz DH: The possible importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 111:86-94, 1982
42. Meda P, Michaels RL, Halban PA, Orci L, Sheridan JD: In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet. Diabetes 32:858-868, 1983
43. Saez JC, Spray DC, Nairn AC, Hertzberg EL, Greengard P, Bennett MVL: cAMP increases junctional conductance and stimulates phosphorylation of the 27-kDa principal gap junction polypeptide. Proc Natl Acad Sci U S A 83: 2473-2477, 1886
44. Murray SA, Fletcher WH: Hormone-induced intercellular signal transfer dissociates cyclic AMP-dependent protein kinase. J Cell Biol 98:1710-1719, 1984